Back to FARALLON CAPITAL MANAGEMENT, L.L.C. FARALLON CAPITAL MANAGEMENT, L.L.C.

ENTAENTA
Showing 8 of 31 quarters

Position history for FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in ENANTA PHARMACEUTICALS INC

FARALLON CAPITAL MANAGEMENT, L.L.C. holds 2.4M shares of ENTA (ENANTA PHARMACEUTICALS INC), worth $35.3M as of 2026-Q2. The position was decreased (-15.8% shares). ENTA represents 0.2% of FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio.

Current Value

$35.3M

Current Shares

2.4M

Total Value Change

+$13.4M

Total Shares Change

+309,940

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2.4M
-15.8%
$35.3M0.2%$14.58
0
2026-Q1
Increased
2.9M
+3.6%
$36.3M0.2%$14.72
36
2025-Q4
Increased
2.8M
+30.6%
$43.7M0.2%$15.90
44
2025-Q3
Unchanged
2.1M
0.0%
$25.4M0.1%$15.16
0
2025-Q2
Unchanged
2.1M
0.0%
$16M0.1%$7.50
0
2025-Q1
Increased
2.1M
+0.7%
$11.7M0.1%$5.71
28
2024-Q4
Unchanged
2.1M
0.0%
$12.1M0.1%$5.85
0
2024-Q3
Increased
2.1M
+0.6%
$21.8M0.1%$10.05
29

Other major holders of ENTA: BNP PARIBAS FINANCIAL MARKETS, NORTHERN TRUST CORP, FIRST MANHATTAN CO. LLC., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used